Results 281 to 290 of about 206,382 (334)

Reply to Letter to the Editor: 'Can Differences in Non-Vitamin K Antagonist Oral Anticoagulant Preferences Result in Varying Clinical Outcomes in Patients with Atrial Fibrillation?' [PDF]

Anatol J Cardiol
Ünlü S, Altay S, Gedikli Ö, Özden Ö, Canpolat U, Aşkın L, Yayla Ç, Yanık A, Çakmak HA, Sinan ÜY, Beşli F, Şahin M, Pehlivanoğlu S.   +12 more
europepmc   +1 more source

Comparing survival with vitamin K antagonists, low-molecular-weight heparin, and direct oral anticoagulants in patients with cancer—a systematic review and meta-analysis

Vasiliki Xirou, Anika Patel, Maria Fernanda Albuja Altamirano, Rishabh Singh, Jason Gusdorf, Kevin J Barnum, Megan McNichol, Justine Ryu, Jeffrey I. Zwicker, Thita Chiasakul, Rushad Patell   +10 more
openalex   +1 more source

Beyond mammals: the evolution of chewing and other forms of oropharyngeal food processing in vertebrates

Biological Reviews, EarlyView.
ABSTRACT Oropharyngeal food processing exhibits a remarkable diversity among vertebrates, reflecting the evolution of specialised ‘processing centres’ associated with the mandibular, hyoid, and branchial arches. Although studies have detailed various food‐processing strategies and mechanisms across vertebrates, a coherent and comprehensive terminology ...
Daniel Schwarz, Maja Mielke, Stephan Handschuh, Anthony Herrel, Patrick Lemell, Léa Da Cunha, Nicolai Konow   +6 more
wiley   +1 more source

Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study. [PDF]

Eur Heart J Qual Care Clin Outcomes
Grymonprez M, Petrovic M, De Backer TL, Steurbaut S, Lahousse L.   +4 more
europepmc   +1 more source

Serum lipids and anticonvulsants [PDF]

, 1982
Berlit, Peter, Heuck, C. C., Krause, Klaus-Henning, Schellenberg, Bernhard   +3 more
core  

Perioperative Management in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Minor Bleeding Risk Procedure: Rationale and Protocol for the PERIXa Study. [PDF]

Vasc Health Risk Manag
Kwon S, Lee SR, Choi EK, Lee KY, Choi J, Ahn HJ, Oh S, Lip GYH.   +7 more
europepmc   +1 more source

Treatment with vitamin K antagonists: patients'quality of life, valuations and adherence

, 2004
Mirjam Locadia
openalex   +1 more source

Risk of Bleeding Following Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Acute Ischemic Stroke Treated With Alteplase.

JAMA Intern Med
Tsai TY, Liu YC, Huang WT, Tu YK, Qiu SQ, Noor S, Huang YC, Chou EH, Lai EC, Huang HK.   +9 more
europepmc   +1 more source